Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1979 2
1980 6
1981 5
1982 3
1983 3
1984 5
1985 7
1986 4
1987 16
1988 15
1989 17
1990 10
1991 9
1992 17
1993 15
1994 20
1995 30
1996 32
1997 21
1998 28
1999 28
2000 42
2001 44
2002 71
2003 73
2004 92
2005 123
2006 114
2007 106
2008 169
2009 176
2010 215
2011 244
2012 276
2013 340
2014 389
2015 460
2016 538
2017 504
2018 566
2019 576
2020 728
2021 779
2022 85
Text availability
Article attribute
Article type
Publication date

Search Results

6,248 results
Results by year
Filters applied: . Clear all
Page 1
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.
He J, Shangguan X, Zhou W, Cao Y, Zheng Q, Tu J, Hu G, Liang Z, Jiang C, Deng L, Wang S, Yang W, Zuo Y, Ma J, Cai R, Chen Y, Fan Q, Dong B, Xue W, Tan H, Qi Y, Gu J, Su B, Eugene Chin Y, Chen G, Wang Q, Wang T, Cheng J. He J, et al. Among authors: hu g. Nat Commun. 2021 Jul 16;12(1):4371. doi: 10.1038/s41467-021-24619-2. Nat Commun. 2021. PMID: 34272364 Free PMC article.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Chen YP, Liu X, Zhou Q, Yang KY, Jin F, Zhu XD, Shi M, Hu GQ, Hu WH, Sun Y, Wu HF, Wu H, Lin Q, Wang H, Tian Y, Zhang N, Wang XC, Shen LF, Liu ZZ, Huang J, Luo XL, Li L, Zang J, Mei Q, Zheng BM, Yue D, Xu J, Wu SG, Shi YX, Mao YP, Chen L, Li WF, Zhou GQ, Sun R, Guo R, Zhang Y, Xu C, Lv JW, Guo Y, Feng HX, Tang LL, Xie FY, Sun Y, Ma J. Chen YP, et al. Among authors: hu gq. Lancet. 2021 Jul 24;398(10297):303-313. doi: 10.1016/S0140-6736(21)01123-5. Epub 2021 Jun 7. Lancet. 2021. PMID: 34111416 Clinical Trial.
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial.
Yang Y, Qu S, Li J, Hu C, Xu M, Li W, Zhou T, Shen L, Wu H, Lang J, Hu G, Luo Z, Fu Z, Qu S, Feng W, Chen X, Lin S, Zhang W, Li X, Sun Y, Lin Z, Lin Q, Lei F, Long J, Hong J, Huang X, Zeng L, Wang P, He X, Zhang B, Yang Q, Zhang X, Zou J, Fang W, Zhang L. Yang Y, et al. Among authors: hu g. Lancet Oncol. 2021 Aug;22(8):1162-1174. doi: 10.1016/S1470-2045(21)00302-8. Epub 2021 Jun 23. Lancet Oncol. 2021. PMID: 34174189 Clinical Trial.
Quo Vadis, Metasurfaces?
Qiu CW, Zhang T, Hu G, Kivshar Y. Qiu CW, et al. Among authors: hu g. Nano Lett. 2021 Jul 14;21(13):5461-5474. doi: 10.1021/acs.nanolett.1c00828. Epub 2021 Jun 23. Nano Lett. 2021. PMID: 34157842 Review.
RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.
Yue Z, Niu X, Yuan Z, Qin Q, Jiang W, He L, Gao J, Ding Y, Liu Y, Xu Z, Li Z, Yang Z, Li R, Xue X, Gao Y, Yue F, Zhang XH, Hu G, Wang Y, Li Y, Chen G, Siwko S, Gartland A, Wang N, Xiao J, Liu M, Luo J. Yue Z, et al. Among authors: hu g. J Clin Invest. 2022 Jan 18;132(2):e144579. doi: 10.1172/JCI144579. J Clin Invest. 2022. PMID: 34847079 Free PMC article.
Interface nano-optics with van der Waals polaritons.
Zhang Q, Hu G, Ma W, Li P, Krasnok A, Hillenbrand R, Alù A, Qiu CW. Zhang Q, et al. Among authors: hu g. Nature. 2021 Sep;597(7875):187-195. doi: 10.1038/s41586-021-03581-5. Epub 2021 Sep 8. Nature. 2021. PMID: 34497390 Review.
6,248 results